drugset / Trial / NCT00362830

A Study of the Alternative Administration of Ixabepilone and Vinflunine

NCT00362830

Phase 1 Completed 60 enrolled Bristol-Myers Squibb
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to test how vinflunine interacts with ixabepilone in the human body.

Timeline

Start
2006-08
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule 30 mg/m2 Intravenous
Subject Ixabepilone Small molecule 40 mg/m2 Intravenous
Subject Vinflunine Small molecule 250 mg/m2 Intravenous
Subject Vinflunine Small molecule 320 mg/m2 Intravenous

Indications